EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update

A disseminated gonococcal infection with spinal locations

Screening for osteoporosis in patients with inflammatory bowel diseases: a cross-sectional study

Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease

Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis

Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers

Detection of Lung Abnormalities in Patients With Rheumatoid Arthritis Who Smoke and Who Were Screened for Lung Cancer With Low-Dose Chest Computed Tomography Imaging in Routine Clinical Care: Results From a Large Multihospital System

Polygenic risk scores for rheumatoid arthritis and idiopathic pulmonary fibrosis and associations with RA, interstitial lung abnormalities, and quantitative interstitial abnormalities among smokers

Increased risk of mortality in lung transplant patients with fragility fractures

Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease

Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA

Value of lung ultrasonography for screening interstitial lung disease in patients with rheumatoid arthritis

Editorial: Pulmonary involvement in systemic autoimmune rheumatic diseases (SARDs): from diagnostic tools to therapeutic strategies

Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15

Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter Study

Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes

Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: Baseline results of SAIL-RA

RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry

Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease

Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts

Hyperparathyroidism in a hemodialyzed patient

2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease

Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Enabling Early Detection and Risk Stratification

Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database

Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study

Gene-respiratory disease interactions for rheumatoid arthritis risk

Salivary gland ultrasonography in patients with connective tissue diseases: a multi-centre observational study

Polymyalgia rheumatica following COVID-19 vaccination: A case-series of ten patients

A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

Clinical features and outcomes of patients with myositis associated-interstitial lung disease

MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression

Recent advances in rheumatoid arthritis-associated interstitial lung disease

Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Predicting abatacept retention using machine learning

Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma

Deep learning-derived quantitative interstitial abnormalities in early rheumatoid arthritis and healthy controls: A multicenter, prospective cross-sectional study

Predicting abatacept retention using machine learning

Rheumatoid arthritis-associated interstitial lung disease: A review

Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis

A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease

Characterisation of airway disease associated with Sjögren disease

Factors associated with anakinra effectiveness and risk of infection in crystal-related flares

Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease

Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series

Methotrexate and rheumatoid arthritis associated interstitial lung disease

Burden of comorbidities: Osteoporotic vertebral fracture during non-small cell lung cancer - the BONE study

Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study

Impact of A Multidisciplinary Team Discussion for Genetic Lung Fibrosis

Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international survey

Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis